Genta Incorporated (GNTA) Tops Q1 EPS by 5c, Comments on Clinical and Regulatory Issues
Tweet Send to a Friend
Genta Incorporated (Nasdaq: GNTA) reports a Q1 loss of $0.04, 5 cents better than estimates. Reveneues were $94K vs ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
